All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 27 points (0.2%) at 17,712 as of Friday, April 1, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,054 issues advancing vs. 1,884 declining with 153 unchanged.

The Health Services industry currently sits up 0.7% versus the S&P 500, which is up 0.1%. Top gainers within the industry include CVS Health ( CVS), up 0.8%, Anthem ( ANTM), up 0.7% and Thermo Fisher Scientific ( TMO), up 0.5%. A company within the industry that fell today was Alibaba Group ( BABA), up 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $0.71 (0.7%) to $108.00 on light volume. Thus far, 685,879 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $106.26-$108.06 after having opened the day at $106.95 as compared to the previous trading day's close of $107.29.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. It operates through three segments: Orthopaedics; MedSurg; and Neurotechnology and Spine. Stryker Corporation has a market cap of $39.9 billion and is part of the health care sector. Shares are up 15.4% year-to-date as of the close of trading on Thursday. Currently there are 14 analysts who rate Stryker Corporation a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Stryker Corporation Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, Baxter International ( BAX) is up $0.34 (0.8%) to $41.42 on light volume. Thus far, 1.8 million shares of Baxter International exchanged hands as compared to its average daily volume of 5.2 million shares. The stock has ranged in price between $40.52-$41.55 after having opened the day at $40.70 as compared to the previous trading day's close of $41.08.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Baxter International Inc. provides a portfolio of renal and hospital products. Its Renal segment provides products and services to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. Baxter International has a market cap of $22.6 billion and is part of the health care sector. Shares are up 7.7% year-to-date as of the close of trading on Thursday. Currently there is 1 analyst who rates Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Baxter International Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, HCA Holdings ( HCA) is up $0.66 (0.8%) to $78.71 on light volume. Thus far, 1.2 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $77.11-$79.36 after having opened the day at $77.82 as compared to the previous trading day's close of $78.05.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $31.0 billion and is part of the health care sector. Shares are up 15.4% year-to-date as of the close of trading on Thursday. Currently there are 14 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income and revenue growth. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full HCA Holdings Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).